SLNO logo
SLNO

Soleno Therapeutics Inc

Biotechnology

Soleno Therapeutics Inc (SLNO) Earnings

Last reported
May 12, 2026
EPS estimate
$0.69
EPS actual
Revenue est.
$95.3M
Revenue actual